表紙
年間契約型資訊服務

藥物輸送科技深入報導

Drug Delivery Insight

出版商 Fitch Solutions, Inc. 商品編碼 8302
出版日期 12 Issues/Year 內容資訊 英文 16 Pages
價格
Back to Top
藥物輸送科技深入報導 Drug Delivery Insight
出版日期: 12 Issues/Year 內容資訊: 英文 16 Pages
簡介
Drug Delivery Insight

Drug Delivery Insight (DDI) 是為您專屬設計針對與藥品最新資訊保持脈動的商務通訊。

DDI 提供您藥物輸送科技 (例如通過肌膚的輸送,緩慢控制釋放及植入 的生技相關送藥科技) 相關企業、商品、疾病、與研究活動的最新資訊。本刊物涵括一般全球注射技術與注射器 產品。

雙週刊 (一年出版22份期刊)。DDI在出刊當日便可 以電子郵件收件。

目錄
Product Code: 1475-083X

BMI View: The use of enduring drug-delivery implants will increase in the long-term as they provide a solution to overcome the prevalent issues of non-compliance, particularly as the burden from chronic diseases increases. However, short-term pressures from cyber security, risks from leakages, and a lack of infrastructure to cater for the implementation will limit near-term uptake.

Table of Contents

  • Compliance Burden Key Driver For Drug-Delivery Implants Corporate News
  • Agreements
  • Nucynta Deal Will More Than Double Depomed's Annual Net Product Sales
  • Vectura/Janssen Sign Deal To Develop Anti-Inflammatory Therapy
  • Seattle Genetics/BMS Enter Clinical Trial Collaboration For Adcetris/Opdivo
  • Vect-Horus/Sanofi Enter Collaboration For Neurodegenerative Diseases
  • Corporate Activities
  • Hospira Unveils Progress On Global Device Strategy
  • BioLight Invests In Newly-Formed Ophthalmic Company Product News
  • Product Approvals
  • FDA Clears t:flex Insulin Pump With Expanded Reservoir
  • FDA Approves AbbVie's Duopa For Motor Fluctuations In Advanced PD Patients
  • La Fenice Insulin Pump Gains Re-Registration Approval In China
  • Flowonix Gains Supplemental PMA For Next-Generation Intrathecal Infusion Device R&D
  • Medical Devices Appetite Growing For 3D Printing
  • Enrolment Begins In Tyrx Absorbable Antibacterial Envelope Trial For CIEDs Infections
  • Novartis Reports Positive Results From Phase III COPD Studies
  • First Of Three Sativex Phase III Cancer Pain Trials Misses Primary Endpoint
  • Photocure Concludes End Of Phase II Status For Cevira In US
  • Patents
  • NSAID Market Set To Welcome Encapsulated Equivalents
  • Oramed Granted Patent In Israel Covering Exenatide
  • Actavis Challenges US Abstral Patents
  • Regulatory Filings
  • Sacituzumab Govitecan Gains FDA Fast Track Designation For TNBC
  • LEO Submits NDA For Calcipotriene+Betamethasone Aerosol Foam In Plaque Psoriasis
  • Neos Submits NDA For Methylphenidate XR-ODT For ADHD
Back to Top